Large Molecule Bioanalysis done differently

To help you achieve more.

BioAgilytix has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

biomarkers

Biomarkers

immunogenicity

Immunogenicity

pharmacokinetics

Pharmacokinetics (PK)

cell-based-assays

Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

biosimilars

Biosimilars

gene-therapy

Gene Therapy

antibody-drug-conjugates

Antibody Drug Conjugates (ADCs)

immuno-oncology

Immuno-oncology

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 1 Day Agoview on linkedin

    BioAgilytix

    A newly developed molecular predictor has the potential to identify patients with melanoma who could benefit from treatment with checkpoint inhibitors. The method incorporates the gene-expression features of spontaneous regression to determine which patients with late-stage melanoma would most likely respond well to targeted antibodies. Learn more via Cancer Therapy Advisor: https://lnkd.in/dueCzit

  • 1 Day Agoview on linkedin

    BioAgilytix

    Cambridge Healthtech Institute’s Immunogenicity & Bioassay Summit will bring scientists together to discuss the latest challenges facing the bioanalytical industry. Interested in attending? There is still time to register and join our team in Washington D.C. on October 22-25. https://lnkd.in/dtUnF_8

  • 4 Days Agoview on linkedin

    BioAgilytix

    As a Principal Investigator with BioAgilytix, you’ll have the opportunity to develop and validate biomarker, cell-based, immunogenicity, immuno- and enzymatic assays to support of innovative drug development projects. Apply today: https://lnkd.in/eW-zg5X